Home » Topics » BioWorld Science

BioWorld Science
RSS

New antifungals from Lilly

Jan. 2, 1998

Alcon discloses new antiglaucoma agents in patent literature

Jan. 2, 1998

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

Abbott synthesizes a novel series of cyclic antifungal agents

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

Raxar --new once-daily fluoroquinolone-- now available in U.S.

Dec. 31, 1997

Cambridge Antibody Technology: FY 1997 highlights

Dec. 31, 1997

FDA deems Provigil approvable

Dec. 31, 1997

Favorable phase III trial results reported for HER2 monoclonal antibody

Dec. 31, 1997

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...